Future Medicinal Chemistry

Future Medicinal Chemistry is a peer-reviewed medical journal covering all aspects of medicinal chemistry, including drug discovery, pharmacology, in silico drug design, structural characterization techniques, ADME-Tox investigations, and science policy, economic and intellectual property issues. It was established in 2009 and is published by Future Science. The editors-in-chief are Iwao Ojima (The State University of New York at Stony Brook) and Jonathan Baell (Monash University).

Future Medicinal Chemistry  
Cover
DisciplineMedical chemistry
LanguageEnglish
Publication details
History2009–present
Publisher
Frequency18/year
3.969 (2017)
Standard abbreviations
ISO 4Future Med. Chem.
Indexing
CODENFMCUA7
ISSN1756-8919 (print)
1756-8927 (web)
OCLC no.762952421
Links

Abstracting and indexingEdit

The journal is abstracted and indexed by BIOSIS Previews, Chemical Abstracts, Chemistry Citation Index, Embase/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 3.556, ranking it 11th out of 60 journals in the category "Chemistry, Medicinal".[1]

ReferencesEdit

  1. ^ "Journals Ranked by Impact: Chemistry, Medicinal". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.

External linksEdit